← Browse by Condition
Medical Condition

locally advanced or metastatic breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06680921 Phase 3
Recruiting

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

Enrollment
460 pts
Location
China
Sponsor
Jiangsu Simcere Pharmaceutical...
View Trial →